DT (10 ng/g body weight) was prepared in PBS supplemented with 1% mouse serum. CD169-DTR and WT mice were administered i.p. with DT according to the infection scheme (Fig S1).
For depletion of NK cells, mice were administered i.p. with 100 μg antimouse NK1.1 (PK136; Invivomab) antibody daily.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.